HYNIC-PSMA is a PSMA-targeting peptide conjugated to a HYNIC chelator, facilitating coordination of technetium or related metals for tracer design. The peptide moiety provides high-affinity binding, while HYNIC offers versatile radiolabeling chemistry. Researchers assess labeling efficiency, stability, and receptor-binding properties. Applications include radiometal-peptide conjugate studies, PSMA-epitope mapping, and imaging-ligand optimization.
HYNIC-PSMA, also known as hydrazinonicotinic acid-conjugated prostate-specific membrane antigen ligand, is a specialized carbohydrate-based compound designed for advanced molecular targeting applications. Featuring a unique structure that enables efficient conjugation with various chelators and radiometals, HYNIC-PSMA has become a valuable tool in the field of molecular imaging and targeted research. Its innovative design facilitates high-affinity binding to PSMA, a cell surface protein widely recognized for its overexpression in certain pathological tissues. The compound's versatility allows it to be incorporated into a range of experimental protocols, making it a prominent choice for scientists seeking precise and reliable molecular probes. By offering robust stability and compatibility with multiple labeling strategies, HYNIC-PSMA supports the development of novel imaging agents and research methodologies that require specificity and sensitivity at the molecular level.
Molecular Imaging Research: HYNIC-PSMA is extensively utilized in molecular imaging research, where it serves as a targeting ligand for the visualization of PSMA-expressing cells. Researchers leverage its strong binding affinity and rapid clearance from non-target tissues to achieve high-contrast images in preclinical models. By labeling the compound with suitable isotopes, scientists can monitor the biodistribution of PSMA-positive cells in real time, facilitating the study of disease progression, tissue localization, and the evaluation of novel imaging agents. The precise targeting offered by this ligand enhances the sensitivity and specificity of imaging protocols, contributing to more accurate data collection and interpretation in experimental settings.
Radiopharmaceutical Development: In the realm of radiopharmaceutical development, HYNIC-PSMA acts as a foundational scaffold for the creation of new radiolabeled compounds. Its HYNIC moiety allows efficient chelation with a variety of radiometals, enabling the synthesis of radiotracers tailored to specific research needs. Scientists use these radiotracers to investigate PSMA expression patterns, optimize imaging protocols, and explore the pharmacokinetics of novel agents. The adaptability of the compound supports the rapid prototyping and optimization of radiopharmaceuticals, accelerating the pace of discovery and innovation in targeted molecular research.
Target Validation Studies: The application of HYNIC-PSMA in target validation studies is particularly significant. By providing a reliable means to detect and quantify PSMA expression in biological samples, this compound aids researchers in confirming the relevance and specificity of PSMA as a biomarker. Experimental protocols often involve the use of labeled ligands to assess binding characteristics, tissue distribution, and cellular uptake, thereby validating the suitability of PSMA for further investigation. This approach ensures that downstream research efforts are focused on well-characterized and validated targets, enhancing the overall efficiency of the discovery pipeline.
Theranostic Research Platforms: HYNIC-PSMA is also instrumental in the development of theranostic research platforms, where it serves as a dual-purpose agent for both diagnostic imaging and targeted delivery studies. By integrating the ligand into multifunctional constructs, researchers can simultaneously monitor target engagement and evaluate the delivery of therapeutic payloads in experimental systems. This dual functionality streamlines the assessment of new therapeutic strategies and supports the design of more effective, targeted interventions in research models.
Basic and Translational Science: In basic and translational science, HYNIC-PSMA enables the exploration of PSMA biology across various experimental contexts. Scientists employ the compound to study receptor-ligand interactions, investigate signaling pathways, and develop new methodologies for cell sorting or enrichment based on PSMA expression. Its versatility and robust performance make it an essential tool for advancing our understanding of PSMA-related mechanisms and for translating fundamental discoveries into practical research applications. Through these diverse roles, HYNIC-PSMA continues to drive innovation and discovery in the field of molecular targeting and carbohydrate compound research.
3. Store-operated Ca2+ entry sustains the fertilization Ca2+ signal in pig eggs
4. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More